Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AGPAT4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | TERF1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | NOVA1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | RENBP | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | LRRC8C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | TATDN2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | ANAPC11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | KCNH7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | SLC7A14 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | PURG | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |